• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    More On SNTS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Santarus, Inc. (SNTS)

    -NasdaqGS
    31.96 0.00(0.00%) Dec 31, 4:00PM EST
    Add to Portfolio
    Prev Close:31.96
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:32.00
    Beta:1.66
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:20.70 - 24,600.00
    Volume:0
    Avg Vol (3m):7,129
    Market Cap:N/A
    P/E (ttm):19.13
    EPS (ttm):1.67
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-13) :N/A
    Quarterly EPS Est (Dec-13) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Santarus, Inc., a specialty biopharmaceutical company, focuses on acquiring, developing, and commercializing proprietary products that address the needs of patients treated by physician specialists. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback